Table 2.
Utilization of aspirin, warfarin, DOAC by race-ethnicity in patients with ischemic stroke and AF.
| Use of Anticoagulation | All | FL-White | FL-Black | FL-Hispanic | PR-Hispanic | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | N | % | N | % | |
| Aspirin* | 9684 | 40.3 | 7480 | 42.2 | 1026 | 43.6 | 1076 | 35.5 | 102 | 11.1 |
| Warfarin* | 7466 | 31.1 | 5499 | 31 | 829 | 35.2 | 864 | 28.5 | 274 | 29.8 |
| DOAC* | 4866 | 20.2 | 3450 | 19.5 | 434 | 18.4 | 746 | 24.6 | 236 | 25.7 |
AF indicates atrial fibrillation; DOAC indicates direct oral anticoagulant; FL indicates Florida; PR indicates Puerto Rico.
P<0.05